VASCUGEN
Live / Registered — Registered (as of 18 Jun 2024)
What this means for you
Registered since 18 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90310251
- Registration number
- 7422401
- Mark type
- Stylized text
- Filed
- 10 Nov 2020
- Published for opposition
- 01 Jun 2021
- Registered
- 18 Jun 2024
- Attorney of record
- Katherine P. Califa
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; medical and scientific research in the field of vascular and cardiovascular impairments; medical and scientific research in the field of allogeneic cell therapy; medical and scientific research in the field of regenerative medicine; providing medical and scientific research information in the field of regenerative medicine, vascular and cardiovascular impairments, and allogenic cell therapies; medical and scientific research in the field of treatment and prevention of critical limb ischemia, diabetic foot ulcer, peripheral artery disease, diabetic retinopathy, age-related macular degeneration, heart failure, stroke, traumatic brain injury, acute kidney injury, acute respiratory distress syndrome, bronchopulmonary dysplasia
Owner
- Vascugen, Inc., Madison, WI, US
- Vascugen, Inc., Madison, WI, US
- Vascugen, Inc., Madison, WI, US
Prosecution history
- 18 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 08 May 2024 — USE AMENDMENT FILED
- 08 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 12 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2023 — SOU EXTENSION 5 GRANTED
- 01 Dec 2023 — SOU EXTENSION 5 FILED
- 11 Dec 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Dec 2023 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jul 2023 — SOU EXTENSION 4 GRANTED
- 13 Jul 2023 — SOU EXTENSION 4 FILED